An Essential Guide to Chiropractic in the United States Military Health System and Veterans Health Administration

OBJECTIVE

The purpose of this article is to provide an essential overview of chiropractic services in United States military and veterans' health care systems.

METHODS

We reviewed literature, legislation, and policies from 1936 through September 2021 pertaining to chiropractic services in the United States military and veterans' health systems. Using these sources and our combined experience in these systems, we identified fundamental themes in the delivery of chiropractic care in the health care systems of the Department of Defense (providing health care for active duty service members) and the Department of Veterans Affairs (providing health care for veterans) in main topic areas.

RESULTS

We identified 7 main topic areas relevant to the 2 systems: populations served by chiropractors; health care systems; integration; utilization and supply of chiropractic care; vetting of chiropractors; roles and evaluation of chiropractors; and oversight and leadership. Key information about chiropractic care in these systems was synthesized into the main topic areas. Benefits of high-quality within-system chiropractic care to active-duty service members and veterans are presented. The assets that within-system chiropractors bring to the Department of Defense and Department of Veterans Affairs health care systems are discussed for each main topic area.

CONCLUSION

This article contains an essential overview of chiropractic services in the Department of Defense and the Department of Veterans Affairs. It offers clarity regarding the integration of chiropractic services into these health care systems and includes a 1-page brief of talking points that may help better inform ongoing discussions of chiropractic services in these 2 different but intertwined environments.

Impact of antihypertensive treatment on resiliency to clinical pain

OBJECTIVES

Although progress has been made in the regulation of hypertension over the past decades, the USA and some other countries have faced a significant rise in incidence of chronic pain management cases during the same period. Studies of the relationship between pain and blood pressure (BP) regulations propose that these two processes may be interconnected. Studies of effects of antihypertensive treatment on pain in general and its chronification have never been reviewed.

METHODS

A narrative review of respective studies with analysis of credibility of the findings was conducted.

RESULTS

Some studies have suggested that aggressive reduction of high BP may contribute to a return in pain symptoms and may require more aggressive, long-term pain management. Other studies propose that long-term antihypertensive medication could also increase the risk for new cases of chronic pain. Pain initiates a central neuroplastic resetting of the baroreceptor activation accounting for sustained increase of BP with an adaptive 'pain-killing' or maladaptive 'pain-complication' effect associated with pain chronification, and these mechanisms may be moderated by antihypertensive medications. However, different antihypertensive drugs and nondrug treatments may diversely affect pain mechanisms at different stages of treatments.

CONCLUSION

Uncontrollable reduction of high BP in some patients with hypertension could increase the risk for chronic pain incidence and its severity. Practical recommendations in BP control should be reconsidered to take into account patients' chronic pain. Further research is needed of moderation effects of different antihypertensive manipulations on pain to improve pain management in these patients.

Pain management program outcomes in veterans with chronic pain and comparison with nonveterans

Background: In Canada, 41% of veterans experience chronic pain compared to the general population (20%). Many veterans with chronic pain also have comorbid disorders such as depression and posttraumatic stress disorder (PTSD), causing increased pain interference and disability.

Aim: This study aims to investigate the effectiveness of a 4-week interdisciplinary pain management program at the Michael G. DeGroote Pain Clinic in Hamilton, Ontario, Canada, and to explore differences in pain experience and treatment outcomes between veterans and nonveterans in the program.

Methods: Data were obtained from psychometric measures completed by 68 veterans and 68 nonveterans enrolled in the pain management program. By matching groups for age and gender, scores were compared between veterans and nonveterans. Outcomes investigated include catastrophizing, pain traumatization, stages of change, acceptance of pain, and program satisfaction. Multivariate analysis of variance (MANOVA) was conducted to examine session (admission–discharge) and group (veteran–nonveteran) differences, and independent t tests were used to examine differences in satisfaction measures.

Results: Results showed that the program was effective for all participants, with significant differences between admission and discharge on several measures. However, veterans experienced significantly greater improvements in pain catastrophizing, kinesiophobia, pain traumatization, pain acceptance, stages of change, and pain coping, compared to nonveterans (P < 0.05). Though no significant differences in program satisfaction were found between groups, case managers evaluated veterans as having achieved greater benefits from the program.

Conclusion: This study presents evidence supporting the effectiveness of an interdisciplinary pain management program in addressing pain-related variables in veterans and nonveterans and provides insight into how pain management is experienced differently by veterans.

Brief Report: Opioid-Involved Overdose Mortality in United States Veterans

BACKGROUND AND OBJECTIVES

The purpose of this study is to assess trends in opioid-involved overdose mortality among US Veterans.

METHODS

Age-adjusted drug overdose mortality rates, overall and by opioid subtype, were assessed from National Death Index data for US Veterans; statistical significance of trends was assessed for 2010 to 2015 and 2015 to 2016.

RESULTS

Veteran age-adjusted overdose mortality rates increased 23.7% from 2010 to 2015 (19.7-24.4 of 100 000) and a further 20.4% through 2016 (29.3 of 100 000). Opioid involvement increased from 51.3% in 2010 to 62.1% in 2016, as opioid overdose rates increased from 10.9 to 19.5 of 100 000. Overdose mortality varied substantially by opioid subtype and demographics.

CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE

This report provides the first-ever description of trends and characteristics of overdose mortality and opioid-involved deaths among US Veterans of military service for the period 2010 to 2016. With the exception of female Veterans and Veterans in Western States, it has been found that trends in Veteran overdose mortality paralleled rising rates of drug overdose observed in the United States more broadly. Published 2020. This article is a U.S. Government work and is in the public domain in the USA. (Am J Addict 2020;00:00-00).

Clinical Strategies for the Treatment and Management of Patients Prescribed Long-term Opioid Therapy

OBJECTIVES

Across diverse health care systems, growing recognition of the harms associated with long-term opioid therapy (LTOT) for chronic pain has catalyzed substantial changes to policy and practice designed to promote safer prescribing and patient care. Although clear goals have been defined, how clinics and providers should most effectively implement these changes has been less well defined, and facilities and providers have had substantial flexibility to innovate.

METHODS

Qualitative interviews were conducted with 24 Department of Veterans Affairs (VA) clinicians across the United States who prescribe LTOT for chronic pain. Interviews probed the practices and initiatives providers utilized to meet opioid safety requirements and address common challenges in caring for patients prescribed LTOT.

RESULTS

Innovative strategies in the design and organization of clinical practice (urine drug testing, informed consent, limiting transfer requests, specialty patient panel) and resources utilized (engaged pharmacists, non-opioid pain treatments, intra-organizational collaborations) are described.

CONCLUSIONS

We conclude with recommendations designed to improve opioid prescribing practices, both within the VA and in other settings.